Symposium over vaccins on 10 and 12 may 2022
- COVID-19 vaccine trials performed in Belgium and regulatory perspective (Nele Steens)
- Setting up vaccine clinical trials in a pandemic context: experience from study site (Fien De Boever)
- Perspective for the future: Vaccinopolis and bioprepardness initiative (Pierre Van Damme)
- European marketing authorization procedure in a pandemic context: challenges and learning (Christophe Focke)
- Follow up of vaccine safety and lessons learned (Jean-Michel Dogné)
- Impact of the COVID-19 pandemic on inspection activities (Karin Froidbise)